The RB/E2F axis is also frequently disrupted in non-viral cancers such as breast cancer, HPV-negative head/neck cancer, and lung cancer (Cancer Genome Atlas Network, 2012; Ertel et al., 2010; Nik-Zainal et al., 2016; Cancer Genome Atlas Network, 2015). Here, RB1 is linked to cancer.